We offer Semaglutide and Retatrutide, two potent GLP-1 receptor agonists designed for research and experimental purposes only. While they serve similar purposes, key differences exist in how they work and what you can expect from each.

Semaglutide mimics the GLP-1 hormone, enhancing insulin secretion in response to high blood sugar levels. It also slows gastric emptying and reduces appetite. Experimental objective: To study blood sugar control, significant weight loss, and decreased risk of cardiovascular events

Retatrutide is an experimental peptide for obesity, a triple glucagon hormone receptor agonist GLP-1 and GCGR receptors said to achieve a more than 17.5% mean weight reduction in adults without diabetes but with obesity or overweight.

Do not use this product to treat or diagnose any medication condition. It is sold mainly for research purposes only. The sprays are not included in this offer. Add 10ml of Bac-water per vial to make the spay version, shake well, and use as desired. Must be a professional care provider or research lab drug company with a valid professional license to order any peptide. Email: raphegenerics@amwiner.com for pricing. 

Minimum quantity: 1-Gram

Ships in 5 to 7 business days of order